Article,

Separation of solubilized A2 adenosine receptors of human platelets from non-receptor 3HNECA binding sites by gel filtration

, , , , and .
Naunyn Schmiedebergs Arch Pharmacol, 337 (1): 64-8 (January 1988)Lohse, M J Elger, B Lindenborn-Fotinos, J Klotz, K N Schwabe, U Germany, west Naunyn-Schmiedeberg's archives of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):64-8..

Abstract

Human platelet membranes were solubilized with the zwitterionic detergent CHAPS (3-3-(cholamidopropyl)-dimethylammonio-1-propanesulfonate) and the solubilized extract subjected to gel filtration. Binding of the adenosine receptor agonist 3HNECA (5'-N-ethylcarboxamidoadenosine) was measured to the eluted fractions. Two 3HNECA binding peaks were eluted, the first of them with the void volume. This first peak represented between 10% and 25% of the 3HNECA binding activity eluted from the column. It bound 3HNECA in a reversible, saturable and GTP-dependent manner with an affinity of 46 nmol/l and a binding capacity of 510 fmol/mg protein. Various adenosine receptor ligands competed for the binding of 3HNECA to the first peak with a pharmacological profile characteristic for the A2 adenosine receptor as determined from adenylate cyclase experiments. In contrast, most adenosine receptor ligands did not compete for 3HNECA binding to the second, major peak. These results suggest that a solubilized A2 receptor-Gs protein complex of human platelets can be separated from other 3HNECA binding sites by gel filtration. This allows reliable radioligand binding studies of the A2 adenosine receptor of human platelets.

Tags

Users

  • @pharmawuerz

Comments and Reviews